Bernard Gilly
Founder bei PIXIUM VISION
Ursprung des Netzwerks ersten Grades von Bernard Gilly
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 37 | |
| Public Company | Medical Specialties | 27 | |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Fovea operates within the ophthalmic pharmaceutical market, which is expected to grow at a double-digit annual rate during the years to come. This growth is likely to be driven by new technologies and products, premium pricing facing no significant reimbursement issues, favorable trends (aging of the population, diabetes epidemiology and environmental factors) and dramatic expansion into the large and mostly untapped market for retinal degenerative diseases. With a limited number of players, the ophthalmology market has proved recently to be an early adopter of innovations, allowing new players to gain visibility very rapidly. During the last three years, Fovea has implemented this strategy, by acquiring products from large pharmaceutical or biotech companies and is actively developing them in four different indications. It has also integrated a unique drug discovery platform and has been able to identify one preclinical candidate and several interesting new targets.
9
| Extinct | Pharmaceuticals: Major | 9 |
Eye Tech Care SA
 Eye Tech Care SA Medical SpecialtiesHealth Technology Eye Tech Care SA develops medical devices for non-invasive eye disease treatment. It offers an ultrasound device which offers a non-invasive treatment that utilizes the ultrasound circular cyclo-coagulation procedure that reduces the intraocular pressure in refractory glaucoma. The firm serves the ophthalmology market in France and Europe. The company was founded by Fabrice Romano, Laurent Farcy and Philippe Chapuis in 2008 and is headquartered in Rillieux-la-Pape, France.
8
| Holding Company | Medical Specialties | 8 |
| Public Company | Biotechnology | 7 | |
Grai Matter Labs SAS
 Grai Matter Labs SAS Information Technology ServicesTechnology Services Grai Matter Labs SAS provides computer programming services. The company was founded on May 9, 2016 and is headquartered in Paris, France.
7
| Holding Company | Information Technology Services | 7 |
Chronolife SAS
 Chronolife SAS Miscellaneous Commercial ServicesCommercial Services Chronolife SAS engages in the research and development activity in natural sciences. The company is headquartered in Paris, France.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Prophesee SA
 Prophesee SA Medical SpecialtiesHealth Technology Prophesee SA engages in the development of neuromorphic vision systems. The firm serves clients in autonomous vehicles, industrial automation, IoT, and security and surveillance. The company was founded by Christoph Posch, Ryad Benosman, Luca Verre, and Bernard Jacques Alex Gilly in 2014 and is headquartered in Paris, France.
5
| Holding Company | Medical Specialties | 5 |
Tilak Healthcare SAS
 Tilak Healthcare SAS Packaged SoftwareTechnology Services Tilak Healthcare SAS develops platform of serious medical games. It enables diagnostic and therapy of ophthalmologic diseases through early detection and self-tracking. The company was founded in 2016 and is headquartered in Paris, France.
4
| Holding Company | Packaged Software | 4 |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.
4
| Private Company | Investment Managers | 4 |
iBionext SAS
 iBionext SAS Investment ManagersFinance iBionext SAS (iBionext) is an independent venture capital firm headquartered in Paris, France. The firm was founded in 2012 by Christophe Bancel and Alexia Perouse.
3
| Private Company | Investment Managers | 3 |
T-Heart SAS
 T-Heart SAS Miscellaneous Commercial ServicesCommercial Services T-Heart SAS is an investment holding company with interest in research and development services on natural sciences sector. The company was founded on December 06, 2018 and is headquartered in Paris, France.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Brainever SAS
 Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France.
2
| Holding Company | Pharmaceuticals: Major | 2 |
PX Therapeutics SA
 PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bernard Gilly
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| EDAP TMS S.A. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
SpineVision SA
 SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Medical Specialties | Chief Executive Officer Director/Board Member | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MAINSTAY MEDICAL INTERNATIONAL | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| Stanford University | College/University | Graduate Degree Graduate Degree | |
Les Laboratoires Servier SAS
 Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. | Investment Managers | Consultant / Advisor Private Equity Investor Private Equity Investor | |
Fournier Pharma SA
 Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Fournier Pharma SA manufactures pharmaceutical products. The firm is also in the engaged in the research, development, production and marketing of molecules. The company has operations in Canada, China, Algeria, Bulgaria, Thailand and Turkey. It was founded in 1880 and is headquartered in Chenôve, France. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Cambridge | College/University | Corporate Officer/Principal Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree | |
| INSEAD | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
| University of California, Berkeley | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| VERIMATRIX | Semiconductors | Director/Board Member Director/Board Member | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO | |
| MAUNA KEA TECHNOLOGIES | Medical Specialties | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| University College London | College/University | Corporate Officer/Principal Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| Télécom Paris | College/University | Graduate Degree Undergraduate Degree | |
Omnes Capital SAS /Venture/
 Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Investment Managers | Director of Investments Private Equity Investor | |
| STENTYS | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst Private Equity Investor Private Equity Investor | |
| EOS IMAGING | Medical Specialties | Chairman Director/Board Member Chief Executive Officer General Counsel Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Chairman Director/Board Member General Counsel | |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Founder Director/Board Member | |
| MCPHY ENERGY | Industrial Machinery | Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MD Start SA
 MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Institut de la Vision
 Institut de la Vision Medical/Nursing ServicesHealth Services Institut de la Vision is a research center located in Paris, France that focuses on discovering, developing, and testing treatments and technological innovations for eye diseases. The French company's objective is to improve the autonomy and quality of life of patients. The private company was founded by José-Alain Sahel. | Medical/Nursing Services | Founder Chief Tech/Sci/R&D Officer | |
Mainstay Medical Ltd.
 Mainstay Medical Ltd. Medical SpecialtiesHealth Technology Mainstay Medical Ltd. operates as a medical device company which develops neuro-stimulation therapies for people with debilitating chronic low back pain. It develops ReActiv8, an active implantable medical device designed to treat people with chronic low back pain. The company was founded by Danny Sachs in 2008 and is headquartered in Dublin, Ireland. | Medical Specialties | Director/Board Member Director/Board Member | |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Tissium SA
 Tissium SA BiotechnologyHealth Technology Tissium SA engages in the development and commercialization of biodegradable sealants and adhesives for invasive surgery. It offers biomimetic wound closure solutions. The company was founded by Bernard J. Gilly, Robert S. Langer, Christophe Bancel, Jeff Karp, Jacques Marescaux, Maria Pereira, and Patrick Houvet in 2013 and is headquartered in Paris, France. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Founder | |
CorWave SA
 CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SparingVision SAS
 SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Founder Founder Director/Board Member | |
| Universite Paris Cite | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Moon Surgical SAS
 Moon Surgical SAS Medical SpecialtiesHealth Technology Moon Surgical SAS is a French medical technology company that is creating a new category of robotic surgery. The company is based in Paris, France and is operated by renowned serial medical innovators and backed by leading venture capitalists. Its Maestro system enhances existing laparoscopic techniques and tools with new capabilities, benefiting the 93%% of patients who currently do not have access to minimally invasive robotic surgery. The CEO of the company is Anne Osdoit. | Medical Specialties | Director/Board Member Director/Board Member | |
May Health SAS
 May Health SAS Miscellaneous Commercial ServicesCommercial Services May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman Chairman | |
Adaptate Biotherapeutics Ltd.
 Adaptate Biotherapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adaptate Biotherapeutics Ltd. engages in research and experimental development on biotechnology. The company was founded on August 21, 2019 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
SafeHeal SAS
 SafeHeal SAS Medical SpecialtiesHealth Technology SafeHeal SAS develops anastomosis protection devices for improved patient recovery and reduced healthcare costs. The company is headquartered in Paris, France. | Medical Specialties | Chairman Director/Board Member | |
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Retinal Degeneration Fund | Director/Board Member Director/Board Member |
Statistik
International
| Frankreich | 31 |
| Vereinigte Staaten | 10 |
| Vereinigtes Königreich | 5 |
| Österreich | 3 |
| Italien | 3 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 5 |
| Finance | 4 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 520 |
| Corporate Officer/Principal | 157 |
| Independent Dir/Board Member | 69 |
| Founder | 67 |
| Chief Executive Officer | 61 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Antoine Papiernik | 48 |
| Donald Jones | 46 |
| Vanessa Giraud | 41 |
| Jean Schmitt | 35 |
| Bernard Chauvin | 34 |
| Hugo Slootweg | 34 |
| Benoît Habert | 34 |
| Michael Wyzga | 31 |
| Mounia Chaoui-Roulleau | 27 |
| Chahra Khaoua Epouse Louafi | 26 |
| Gérard Hascoët | 25 |
| Guido Magni | 23 |
| Bernard Daugeras | 23 |
| Rafaèle Elisabeth Tordjman | 23 |
| Barrett Katz | 23 |
- Börse
- Insiders
- Bernard Gilly
- Unternehmensverbindungen
